Welcome to the e-CCO Library!

Y-ECCO Literature Review: Local barrier dysfunction identifi ed by confocal laser endomicroscopy predicts relapse in infl ammatory bowel disease
Source: ECCO News Issue 01/2012
Authors: Pascal Jullerat
Y-ECCO Literature Review: Loss of infliximab into feces is associated with lack of response to therapy in patients with severe Ulcerative Colitis
Source: ECCO News Issue 04/2015
Authors: Spyros Siakavellas
Y-ECCO Literature Review: Loss of interleukin-10 signaling and infantile Infammatory Bowel Disease – implications for diagnosis and therapy
Source: ECCO News Issue 03/2012
Authors: Donata Lissner
Y-ECCO Literature Review: Maintenance of remission among patients with Crohn’s disease on antimetabolite therapy after infliximab therapy is stopped
Source: ECCO News Issue 04/2011
Authors: Monica Cesarini
Y-ECCO Literature Review: Maternal Inflammatory Bowel Disease has short and long-term effects on the health of their offspring: A multicenter study in Israel
Source: ECCO News Issue 01/2013
Authors: Marco Gasparetto
Y-ECCO Literature Review: Measurement of Fecal Calprotectin improves monitoring and detection of recurrence of Crohn’s disease after surgery
Source: ECCO News Issue 02/2015
Authors: Tom Holvoet
Y-ECCO Literature Review: Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn’s disease
Source: ECCO News Issue 01/2012
Authors: Peter Bossuyt
Y-ECCO Literature Review: Mortality and causes of death in Crohn’s Disease: Results from 20 years of followup in the IBSEN study
Source: ECCO News Issue 02/2014
Authors: Pedro Magalhães-Costa
Y-ECCO Literature Review: Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study
Source: ECCO News Issue 02/2013
Authors: Beatrijs Strubbe
Y-ECCO Literature Review: Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study
Source: ECCO News Issue 02/2013
Authors: Loris R. Lopetuso
Y-ECCO Literature Review: Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol
Source: ECCO News Issue 03/2012
Authors: Nanne de Boer
Y-ECCO Literature Review: Ozanimod induction and maintenance treatment for Ulcerative Colitis
Source: ECCO News Issue 03/2016
Authors: Jonathan Segal
Y-ECCO Literature Review: PPARα-UGT axis activation represses intestinal FXR-FGF15 feedback signaling and exacerbates experimental colitis
Source: ECCO News Issue 04/2014
Authors: Marco Genua
Y-ECCO Literature Review: Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with Inflammatory Bowel Disease
Source: ECCO News Issue 03/2015
Authors: Lea Isabell Kredel
Y-ECCO Literature Review: Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn’s disease from UC.
Source: ECCO News Issue 03/2016
Authors: Bram Verstockt
Y-ECCO Literature Review: Rapid fucosylation of intestinal epithelium sustains host–commensal symbiosis in sickness
Source: ECCO News Issue 01/2015
Authors: Nadine Waldschmitt
Y-ECCO Literature Review: Recombinant human erythropoietin in patients with infl ammatory bowel disease and refractory anemia: A 15-year single-center experience
Source: ECCO News Issue 02/2012
Authors: Johan Burisch
Y-ECCO Literature Review: Risk for colorectal neoplasia in patients with colonic Crohn’s disease and concomitant primary sclerosing cholangitis
Source: ECCO News Issue 02/2012
Authors: Raja Affendi Raja Ali
Y-ECCO Literature Review: Risk of cancer in patients with inflammatory bowel disease and venous thromboembolism: a nationwide cohort study
Source: ECCO News Issue 02/2012
Authors: Reingard Platzer
Y-ECCO Literature Review: Risk of colorectal cancer and small bowel adenocarcinoma in Crohn’s disease: A population-based study from western Hungary 1977–2008.
Source: ECCO News Issue 02/2011
Authors: Catherine Reenaers